Arrowhead Pharmaceuticals Inc
XMUN:HDP1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Arrowhead Pharmaceuticals Inc (HDP1) under the Base Case is EUR per share.
Compared with the current market price of 51.64 EUR, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Arrowhead Pharmaceuticals Does
Arrowhead Pharmaceuticals is a biotechnology company that designs medicines based on RNA interference, a way to turn down the production of harmful proteins inside the body. Its main work is developing drug candidates for diseases such as rare genetic disorders, liver-related conditions, and other illnesses where reducing a specific target protein may help patients.
- Headquarters
- United States of America US
- Employees
- 711
- IPO date
- Dec 14, 1993
Revenue & Expenses Breakdown
Arrowhead Pharmaceuticals Inc
Earnings Waterfall
Arrowhead Pharmaceuticals Inc
What is the Intrinsic Value of one HDP1 stock?
The intrinsic value for Arrowhead Pharmaceuticals Inc (HDP1) under the Base Case is EUR.
Is HDP1 stock undervalued or overvalued?
Compared with the current market price of 51.64 EUR, the stock appears .
